Analytical Data
-
Gene name
C1orf53
- Application
-
Alternative Names
C1orf53; Uncharacterized Protein C1orf53
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5VUE5
-
Expression Region
1-145aa
-
AA Sequence
MAARQIWART GAALCRQPSA APPPAPLWVR AGFRQQLSLT LCPANEGNCG GSAPSTPGRP ERAARPSVSE ELTAAERQIA ELHAAACAAG QLNYVDPATG YVVLTQIAHL QRGECCGSAC RHCPYGQVNV KDPSKKKQFN SYFYV
-
Molecular Weight
16 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1orf53, also known as PDC, is a relatively uncharacterized protein that has garnered research interest due to its potential relevance in various biological processes and disease mechanisms. Initial studies have suggested that C1orf53 may play a role in cellular functions such as proliferation, apoptosis, and differentiation, potentially implicating it in cancer biology and other pathologies. As a member of a poorly defined protein family, its structure and function remain largely elusive. Advances in recombinant protein technology have enabled researchers to produce C1orf53 in higher quantities for functional assays, facilitating investigations into its biochemical properties and interactions with other cellular components. Understanding the role of C1orf53 may not only shed light on its specific function in normal physiology but also provide insights into its aberrant expression in diseases. Furthermore, elucidating the signaling pathways and molecular mechanisms involving C1orf53 could reveal novel therapeutic targets for intervention in cancer and other disorders where its function is disrupted. Consequently, the study of C1orf53 recombinant protein is a promising area of research that holds potential for unveiling new aspects of cellular regulation and disease pathology.
